Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.56 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.56 |
| ▸ | PARP1 | P09874 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | KCNK3 | O14649 | 4/20 | 0.51 |
| ▸ | KCNK9 | Q9NPC2 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.49 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.47 |
| ▸ | WNT3A | P56704 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7946186 | 0.88 | CES2 (0.55) | HDAC8HDAC6PARP1KMT2ANPC1 | |
| SCHEMBL31296680 | 0.87 | POLB (0.54) | HDAC8HDAC6PARP1SMN1; SMN2KCNK3 | |
| SCHEMBL3753879 | 0.83 | PARP1 (0.68) | HDAC8HDAC6PARP1SMN1; SMN2KCNK3 | |
| SCHEMBL6556383 | 0.81 | HDAC8 (0.53) | HDAC8HDAC6PARP1SMN1; SMN2KCNK3 | |
| SCHEMBL2007367 | 0.81 | TDP1 (0.53) | HDAC8HDAC6PARP1SMN1; SMN2KCNK3 | |
| SCHEMBL28662743 | 0.81 | TSHR (0.55) | SMN1; SMN2MEN1KMT2ANPC1RAB9A | |
| SCHEMBL9432396 | 0.81 | CA12 (0.53) | PARP1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL30973065 | 0.80 | PARP1 (0.50) | HDAC8HDAC6PARP1SMN1; SMN2KCNK3 | |
| SCHEMBL40429 | 0.80 | GPR17 (0.65) | HDAC8HDAC6PARP1SMN1; SMN2KCNK3 | |
| SCHEMBL29534771 | 0.80 | GPR17 (0.65) | HDAC8HDAC6PARP1SMN1; SMN2KCNK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-3157350-A | — | — | None | — | — | JP | disclosed |
| US-20260070874-A1 | BENZOYLFORMIC ACID AMIDE DERIVATIVE | KJ CHEMICALS CORPORATION (JP) | 2026-03-12 | — | — | US | disclosed |
| EP-4610249-A1 | BENZOYLFORMIC ACID AMIDE DERIVATIVE | KJ Chemicals Corporation (JP) | 2025-09-03 | — | — | EP | disclosed |
| WO-2024210074-A1 | BENZOYLFORMIC ACID AMIDE DERIVATIVE | ＫＪケミカルズ株式会社 | 2024-10-10 | — | — | WO | disclosed |
| EP-3871857-B1 | POLYMER MEMBER PRODUCTION METHOD | ASICS CORP (JP) | 2024-02-07 | — | — | EP | disclosed |
| US-11884003-B2 | Method for producing polymer member | ASICS CORPORATION (JP) | 2024-01-30 | — | — | US | disclosed |
| CN-113453873-B | Method for producing polymer member | 株式会社爱世克私 | 2023-04-04 | — | — | CN | disclosed |
| CN-113453873-A | Method for producing polymer member | 株式会社爱世克私 | 2021-09-28 | — | — | CN | disclosed |
| US-20120178743-A1 | NOVEL ADENINE COMPOUND AND USE THEREOF | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2012-07-12 | — | — | US | disclosed |
| EP-1550662-B1 | ADENINE COMPOUND AND USE THEREOF | DAINIPPON SUMITOMO PHARMA CO (JP) | 2012-07-04 | — | — | EP | disclosed |
| WO-2001012590-A1 | OXYME AMIDES AND HYDRAZONE AMIDES HAVING FUNGICIDAL ACTIVITY | MONSANTO TECHNOLOGY LLC (US) | 2001-02-22 | — | — | WO | disclosed |
| US-6143931-A | USEFUL IN DEVELOPING PHARMACEUTIC AGENTS FOR THE TREATMENT OF DISEASES (E.G., CHAGAS' DISEASE) | ARQULE, INC. (US) | 2000-11-07 | — | — | US | disclosed |
| EP-0975584-A1 | SYNTHESIS AND USE OF $g(a)-KETOAMIDE DERIVATIVES AND ARRAYS | ARQULE, INC. (US) | 2000-02-02 | — | — | EP | disclosed |
| WO-1998046551-A9 | SYNTHESIS AND USE OF BIASED ARRAYS | — | 1999-03-18 | — | — | WO | disclosed |
| WO-1998046559-A1 | SYNTHESIS AND USE OF α-KETOAMIDE DERIVATIVES AND ARRAYS | ARQULE, INC. (US) | 1998-10-22 | — | — | WO | disclosed |
| WO-1998046551-A1 | SYNTHESIS AND USE OF BIASED ARRAYS | ARQULE, INC. (US) | 1998-10-22 | — | — | WO | disclosed |
| EP-0422597-B1 | Derivatives of phenylacetic acid and fungicides containing them | BASF AG (DE) | 1996-07-24 | — | — | EP | disclosed |
| US-5286750-A | For crops or ornamental plants | BASF AKTIENGESELLSCHAFT (DE) | 1994-02-15 | — | — | US | disclosed |
| JP-H03157350-A | PHENYLACETIC ACID DERIVATIVE AND FUNGICIDE CONTAINING IT | BASF AG | 1991-07-05 | — | — | JP | disclosed |
| EP-0422597-A2 | Derivatives of phenylacetic acid and fungicides containing them | BASF Aktiengesellschaft (DE) | 1991-04-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178743-A1 | NOVEL ADENINE COMPOUND AND USE THEREOF | ADORA1, HRH4, P2RY10 | HDAC8 1160/4885HDAC6 1052/4885PARP1 896/4885 |
| US-20260070874-A1 | BENZOYLFORMIC ACID AMIDE DERIVATIVE | CRYAA, BCAT1, BRCA1 | HDAC8 1399/4885HDAC6 972/4885PARP1 1807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.